Bryan Kluck, DO
Cardiovascular Disease · Allentown, PANPI 1659486959
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Johnson & Johnson at 39.1% of the total. Reporting peaked in 2019 at $40,389 and has fallen 99.2% since, to $331 in 2025. Among cardiovascular disease clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 325 payments — averaging $185.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$24K
- Boston Scientific$14K
- Chiesi USA, Inc.$6K
- Abiomed$5K
- Angiodynamics, Inc.$4K
- Medtronic$3K
- plus $6K from 30 others
Across 23 payments — averaging $1702.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- W. L. Gore & Associates, Inc.$39K
What the payments were for
- Consulting fees$8,31314%
- Speaking & faculty fees$35,40059%
- Travel & lodging$4,2057%
- Food & beverage$8,70414%
- Education$430%
- Gifts$750%
- Other$3,5426%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 46 | $23,550 |
| Boston Scientific | 91 | $13,858 |
| Chiesi USA, Inc. | 15 | $5,525 |
| Abiomed | 26 | $4,659 |
| Angiodynamics, Inc. | 1 | $3,542 |
| Medtronic(2 entities) | 11 | $3,211 |
| Portola Pharmaceuticals, LLC | 4 | $2,487 |
| Biotronik Inc. | 8 | $506 |
| Tactile Systems Technology Inc | 16 | $412 |
| Novartis | 16 | $326 |
| Abbott | 10 | $315 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $235 |
| E.r. Squibb & Sons, L.L.C. | 12 | $224 |
| Boehringer Ingelheim | 8 | $154 |
| Bard Peripheral Vascular, Inc. | 3 | $125 |
| AstraZeneca | 3 | $121 |
| Cardiovascular Systems Inc. | 1 | $118 |
| Esperion Therapeutics, Inc. | 6 | $113 |
| Amgen | 6 | $112 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $99 |
| Philips North America LLC | 1 | $81 |
| Actelion Pharmaceuticals US, Inc. | 3 | $76 |
| Edwards Lifesciences | 4 | $73 |
| Pfizer | 4 | $71 |
| Novo Nordisk | 3 | $58 |
| Reflow Medical Inc | 1 | $37 |
| Infobionic, Inc | 1 | $27 |
| Merck | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Inari Medical, Inc. | 1 | $20 |
| GSK | 1 | $19 |
| Bayer | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Cardiva Medical, Inc. | 1 | $17 |
| Braemar Manufacturing, LLC | 1 | $16 |
| Cashflow Solutions, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$23,016
- GENERAL VASCULAR INTERVENTION$9,113
- KENGREAL$5,280
- Impella$4,229
- Auryon Laser System 100-120 Vac$3,542
- VenaSeal$2,800
- ANDEXXA$2,466
- GENERAL - THERAPIES$1,348
- Watchman$1,110
- GENERAL ATHERECTOMY$438
- GENERAL PELVIC ORGAN PROLAPSE$215
- WATCHMAN Access System$134
- GENERAL - STENTS$132
- Resolute$125
- GENERAL METALLIC STENTS$125
- GENERAL - STRUCTURAL HEART$124
- Peripheral Orbital Atherectomy System$118
- Coronary Orbital Atherectomy System$118
- Orsiro Mission$110
- ReCross$110
How this compares
$60,282 in reported general payments places this provider in the 95th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Allentown
- Sabahat BokhariAllentown$578K
- Matthew MartinezAllentown$419K
- Steven ZelenkofskeAllentown$103K
- Hemal GadaWormleysburg$1.8M
- Benjamin KalsmithPgh$1.7M
- Peter KoweyWynnewood$1.5M
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Rhian DaviesYork$853K
- Sarang MangalmurtiBryn Mawr$728K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.